Voltar
Revisão Revisado por pares
BIBTEX RIS

GABA synaptic mechanisms: Stereochemical and conformational requirements

1988; Wiley; Volume: 8; Issue: 1 Linguagem: Inglês

10.1002/med.2610080103

ISSN

1098-1128

Autores

Povl Krogsgaard‐Larsen,

Tópico(s)

GABA and Rice Research

Resumo

Medicinal Research ReviewsVolume 8, Issue 1 p. 27-56 Article GABA synaptic mechanisms: Stereochemical and conformational requirements Povl Krogsgaard-Larsen, Povl Krogsgaard-Larsen Department of Chemistry. BC, The Royal Danish School of Pharmacy, 2 Universitetsparken, DK-2100 Copenhagen, DenmarkSearch for more papers by this author Povl Krogsgaard-Larsen, Povl Krogsgaard-Larsen Department of Chemistry. BC, The Royal Danish School of Pharmacy, 2 Universitetsparken, DK-2100 Copenhagen, DenmarkSearch for more papers by this author First published: January/March 1988 https://doi.org/10.1002/med.2610080103Citations: 70AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 D. R. Curtis and G. A. R. Johnston, Ergebn. Physiol., 69, 97 (1974). 2 K. Krnjević, Physiol. Rev., 54, 418 (1974). 3 E. Roberts, T. N. Chase, and D. B. Tower, Eds., GABA in Nervous System Function, Raven, New York, 1976. 4 F. Fonnum, Ed., Amino Acids as Chemical Transmitters, Plenum, New York, 1978. 5 P. Krogsgaard-Larsen, J. Scheel-Krüger and H. Kofod, Eds., GABA-Neutrotransmitters. Pharmacochemical, Biochemical and Pharmacological Aspects, Munksgaard, Copenhagen, 1979. 6 G. Racagni and A. O. Donoso, Eds., GABA and Endocrine Function, Raven, New York, 1986. 7 E. E. Müller, D. Cocchi, V. Locatelli, J. A. Apud, M. L. Tappaz, C. Masotto, A. Novelli, and G. Racagni, in The GABA Receptors, S. J. Enna, Ed., The Humana Press, Clifton, N.J., 1983, p. 257. 8 S. J. Enna, Biochem. Pharmacol., 30, 907 (1981). 9 M. J. Antonaccio, L. Kerwin, and D. G. Taylor, Neuropharmacology, 17, 597 (1978). 10 M. J. Antonaccio, L. Kerwin, and D. G. Taylor, Neuropharmacology, 17, 783 (1978). 11 J. A. DiMicco, K. Gale, B. Hamilton, and R. A. Gillis, Science, 204, 1106 (1979). 12 F. V. DeFeudis, Neurochem. Int., 3, 113 (1981). 13 J. A. DiMicco, N. L. Alsip, and J. H. Wible, Neuropharmacology, 23, 819 (1984). 14 I. K. Ho, H. H. Lok, and E. L. Way, Life Sci., 18, 1111 (1976). 15 F. V. DeFeudis, Prog. Neurobiol., 19, 1 (1982). 16 R. C. Hill, R. Maurer, H.-H. Buescher, and D. Roemer, Eur. J. Pharmacol., 69, 221 (1981). 17 T. Andree, D. A. Kendall, and S. J. Enna, Life Sci., 32, 2265 (1983). 18 A. Grognet, F. Hertz, and F. V. DeFeudis, Gen. Pharmacol., 14, 585 (1983). 19 S. H. Zorn, L. J. Willmore, C. M. Bailey, and S. J. Enna, in Neurotransmitters, Seizures, and Epilepsy III, G. Nistico, P. L. Morselli, K. G. Lloyd, R. G. Fariello, and J. Engel, Eds., Raven, New York, 1986, p. 123. 20 R. Hoehn-Saric, Psychopharmacology, 80, 338 (1983). 21 J. A. Gray, J. Mellanby, and C. Buckland, Neuropharmacology, 23, 827 (1984). 22 N. Blavet, F. V. DeFeudis, and F. Clostre, Psychopharmacology, 76, 75 (1982). 23 P. Mandel, L. Ciesielski, M. Maitre, S. Simler, G. Mack, and E. Kempf, in GABA—Biochemistry and CNS Functions, P. Mandel and F. V. DeFeudis, Eds., Plenum, New York, 1979, p. 475. 24 R. G. Fariello, P. L. Morselli, K. G. Lloyd, L. F. Quesney, and J. Engel, Eds., Neurotransmitters, Seizures, and Epilepsy II, Raven, New York, 1984. 25 G. Nistico, P. L. Morselli, K. G. Lloyd, R. G. Fariello, and J. Engel, Eds., Neurotransmitters, Seizures, and Epilepsy III, Raven, New York, 1986. 26 C. E. Ribak, A. B. Harris, L. Anderson, J. E. Vaughn, and E. Roberts, Science, 205, 211 (1979). 27 S. M. Ross and C. R. Craig, J. Neurochem., 36, 1006 (1981). 28 T. N. Chase, N. S. Wexler, and A. Barbeau, Eds., Huntington's Disease, Raven, New York, 1979. 29 S. J. Enna, E. D. Bird, J. P. Bennett, D. B. Bylund, H. I. Yamamura, L. L. Iversen, and S. H. Snyder, N. Engl. J. Med., 294, 1305 (1976). 30 K. G. Lloyd, L. Shemen, and O. Hornykiewicz, Brain Res., 127, 269 (1977). 31 J. Stevens, K. Wilson, and W. Foote, Psychopharmacologia, 39, 105 (1974). 32 D. P. Van Kammen, Am. J. Psychiatry, 134, 138 (1977). 33 F. Petty and J. A. Coffman, Neuropharmacology, 23, 859 (1984). 34 P. Davies, Brain Res., 171, 319 (1979). 35 K. G. Lloyd and A. Pilc, Neuropharmacology, 23, 841 (1984). 36 D. R. Curtis, A. W. Duggan, D. Felix, and G. A. R. Johnston, Brain Res., 32, 69 (1971). 37 D. R. Curtis, D. Lodge, J. C. Bornstein, M. J. Peet, and J. D. Leah, Exp. Brain Res., 48, 387 (1982). 38 P. Krogsgaard-Larsen, L. Nielsen, E. Falch, and D. R. Curtis, J. Med. Chem., 28, 1612 (1985). 39 P. Krogsgaard-Larsen, H. Mikkelsen, P. Jacobsen, E. Falch, D. R. Curtis, M. J. Peet, and J. D. Leah, J. Med. Chem., 26, 895 (1983). 40 S. J. Enna and S. H. Snyder, Brain Res., 100, 81 (1975). 41 E. Falch and P. Krogsgaard-Larsen, J. Neurochem., 38, 1123 (1982). 42 C. Braestrup, M. Nielsen, P. Krogsgaard-Larsen, and E. Falch, Nature (London), 280, 331 (1979). 43 E. Falch, P. Jacobsen, P. Krogsgaard-Larsen, and D. R. Curtis, J. Neurochem., 44, 68 (1985). 44 E. Falch, P. Krogsgaard-Larsen, P. Jacobsen, A. Engesgaard, C. Braestrup, and D. R. Curtis, Eur. J. Med. Chem., 20, 447 (1985). 45 D. R. Hill and N. G. Bowery, Nature (London), 290, 149 (1981). 46 E. Falch, A. Hedegaard, L. Nielsen, B. R. Jensen, H. Hjeds, and P. Krogsgaard-Larsen, J. Neurochem., 47, 898 (1986). 47 A. Schousboe, P. Thorbek, L. Hertz, and P. Krogsgaard-Larsen, J. Neurochem., 33, 181 (1979). 48 M. Sensenbrenner, K. Maderspach, L. Latzkovits, and G. G. Jaros, Develop. Neurosci., 1, 90 (1978). 49 O. M. Larsson, G. A. R. Johnston, and A. Schousboe, Brain Res., 260, 279 (1983). 50 J. Booher and M. Sensenbrenner, Neurobiology, 2, 97 (1972). 51 A. Schousboe, P. Krogsgaard-Larsen, G. Svenneby, and L. Hertz, Brain Res., 153, 623 (1978). 52 B. Fjalland, Acta Pharmacol. Toxicol., 42, 73 (1978). 53 P. Mandel and F. V. DeFeudis, Eds., GABA—Biochemistry and CNS Functions, Plenum, New York, 1979. 54 Y. Okada and E. Roberts, Eds., Problems in GABA Research from Brain to Bacteria, Excerpta Medica, Amsterdam, 1982. 55 L. Hertz, E. Kvamme, E. G. McGeer, and A. Schousboe, Eds., Glutamine, Glutamate, and GABA in the Central Nervous System, Alan R. Liss, New York, 1983. 56 D. C. Spink and D. L. Martin, in Glutamine, Glutamate, and GABA in the Central Nervous System, L. Hertz, E. Kvamme, E. G. McGeer, and A. Schousboe, Eds., Alan R. Liss, New York, 1983, p. 129. 57 P. J. Roberts, J. Storm-Mathisen, and H. F. Bradford, Eds., Excitatory Amino Acids, MacMillan, London, 1986. 58 H. F. Bradford, In Handbook of Psychopharmacology, Vol. 1, L. L. Iversen, S. D. Iversen, and S. H. Snyder, Eds., Plenum, New York, 1975, p. 191. 59 N. G. Bowery, in The GABA Receptors, S. J. Enna, Ed., The Humana Press, Clifton, N.J., 1983, p. 177. 60 C. Arias and R. Tapia, J. Neurochem., 47, 396 (1986). 61 L. L. Iversen and M. J. Neal, J. Neurochem., 15, 1141 (1968). 62 L. L. Iversen and G. A. R. Johnston, J. Neurochem., 18, 1939 (1971). 63 D. L. Martin, in GABA in Nervous System Function, E. Roberts, T. N. Chase and D. B. Tower, Eds., Raven, New York, 1976, p. 347. 64 A. Schousboe, Int. Rev. Neurobiol., 22, 1 (1981). 65 P. Krogsgaard-Larsen, E. Falch, O. M. Larsson, and A. Schousboe, Epilepsy Res., 1, 77 (1987). 66 G. Levi and M. Raiteri, Life Sci., 12, 81 (1973). 67 R. J. Hitzemann and H. H. Lok, J. Neurochem., 30, 471 (1978). 68 J. D. Wood and H. S. Sidhu, J. Neurochem., 46, 739 (1986). 69 O. M. Larsson, P. Krogsgaard-Larsen, and A. Schousboe, Neurochem. Int., 7, 853 (1985). 70 A. Cupello and H. Hydén, Cell. Mol. Neurobiol., 6, 1 (1986). 71 T. N. Chase and J. R. Walters, in GABA in Nervous System Function, E. Roberts, T. N. Chase, and D. B. Tower, Eds., Raven, New York, 1976, p. 497. 72 S. R. Snodgrass, Nature ( London), 274, 392 (1978). 73 M. J. W. Brennan and R. C. Cantrill, Nature ( London), 280, 514 (1979). 74 M. J. W. Brennan, R. C. Cantrill, M. Oldfield, and P. Krogsgaard-Larsen, Mol. Pharmacol., 19, 27 (1981). 75 J.-P. Chambon, P. Feltz, M. Heaulme, S. Restle, R. Schlichter, K. Biziere, and C. G. Wermuth, Proc. Natl. Acad. Sci. USA, 82, 1832 (1985). 76 J. R. Byberg, D. R. Curtis, B. D. Gynther, I. M. Labouta, E. Falch, H. Hjeds, and P. Krogsgaard-Larsen, Drug Design and Delivery, 1, 261 (1987). 77 M. J. Jung, B. W. Metcalf, B. Lippert, and P. Casara, Biochemistry, 17, 2628 (1978). 78 M. G. Palfreyman, P. J. Schechter, W. R. Buckett, G. P. Tell, and J. Koch-Weser, Biochem. Pharmacol., 30, 817 (1981). 79 C. Walsh, Annu. Rev. Biochem., 53, 493 (1984). 80 R. R. Rando, Pharmacol. Rev., 36, 111 (1984). 81 R. B. Silverman and S. J. Hoffman, Med. Res. Rev., 4, 415 (1984). 82 P. J. Schechter, N. F. J. Hanke, J. Grove, N. Huebert, and A. Sjoerdsma, Neurology, 34, 182 (1984). 83 P. A. Lambert, P. Cantiniaux, J.-P. Chabannes, G. P. Tell, P. J. Schechter, and J. Koch-Weser, Encephale, 8, 371 (1982). 84 P. Krogsgaard-Larsen, Mol. Cell. Biochem., 31, 105 (1980). 85 P. Krogsgaard-Larsen, E. Falch, and H. Hjeds, Prog. Med. Chem., 22, 67 (1985). 86 P. Krogsgaard-Larsen, E. Falch, A. Schousboe, and D. R. Curtis, in Neurotransmitters, Seizures and Epilepsy III, G. Nistico, P. L. Morselli, K. G. Lloyd, R. G. Fariello, and J. Engel, Eds., Raven, New York, 1986, p. 135. 87 P. Krogsgaard-Larsen, I. M. Labouta, B. Meldrum, M. Croucher, and A. Schousboe, in Neurotransmitters, Seizures, and Epilepsy, P. L. Morselli, W. Löscher, K. G. Lloyd, B. Meldrum, and E. H. Reynolds, Eds., Raven, New York, 1981, p. 23. 88 R. W. Horton, J. F. Collins, G. M. Anlezark, and B. S. Meldrum, Eur. J. Pharmacol., 59, 75 (1979). 89 H.-H. Frey, C. Popp, and W. Löscher, Neuropharmacology, 18, 581 (1979). 90 M. J. Croucher, B. S. Meldrum, and P. Krogsgaard-Larsen, Eur. J. Pharmacol., 89, 217 (1983). 91 S. J. Enna, Ed., The GABA Receptors, The Humana Press, Clifton, N.J., 1983. 92 N. G. Bowery, Ed., Actions and Interactions of GABA and Benzodiazepines, Raven, New York, 1984. 93 D. R. Curtis, in Amino Acids as Chemical Transmitters, F. Fonnum, Ed., Plenum, New York, 1978, p. 55. 94 M. A. Simmonds, in Actions and Interactions of GABA and Benzodiazepines, N. G. Bowery, Ed., Raven, New York, 1984, p. 27. 95 D. R. Curtis and R. Malik, Proc. Roy Soc. London, B223, 25 (1984). 96 D. A. Brown, Trends Neurosci., 2, 271 (1979). 97 B. E. Alger and R. A. Nicoll, J. Physiol., 328, 125 (1982). 98 P. Krogsgaard-Larsen, in Glutamine, Glutamate and GABA in the Central Nervous System, L. Hertz, E. Kvamme, E. G. McGeer, and A. Schousboe, Eds., Alan R. Liss, New York, 1983, p. 537. 99 K. Kato, M. Goto, and H. Fukuda, Gen. Pharmacol., 13, 445 (1982). 100 N. Ogata, M. Inoue, and T. Matsuo, Synapse, 1, 62 (1987). 101 N. G. Bowery, D. R. Hill, A. L. Hudson, G. W. Price, M. J. Turnbull, and G. P. Wilkin, in Actions and Interactions of GABA and Benzodiazepines, N. G. Bowery, Ed., Raven, New York, 1984, p. 81. 102 S. J. Enna and S. H. Snyder, Mol. Pharmacol., 13, 442 (1977). 103 N. G. Bowery, D. R. Hill, and A. L. Hudson, Br. J. Pharmacol., 78, 191 (1983). 104 G. P. Wilkin, A. L. Hudson, D. R. Hill, and N. G. Bowery, Nature, 274, 584 (1981). 105 J. M. Palacios, W. Scott Young, and M. J. Kuhar, Proc. Natl. Acad. Sci. USA, 77, 670 (1980). 106 K. J. Watling and D. R. Bristow, J. Neurochem., 46, 1755 (1986). 107 G. A. R. Johnston and R. D. Allan, Neuropharmacology, 23, 831 (1984). 108 C. A. Drew, G. A. R. Johnston, and R. P. Weatherby, Neurosci. Lett., 52, 317 (1984). 109 G. A. R. Johnston, D. R. Curtis, P. M. Beart, C. J. A. Game, R. M. McCulloch, and B. Twitchin, J. Neurochem., 24, 157 (1975). 110 P. Krogsgaard-Larsen, G. A. R. Johnston, D. R. Curtis, C. J. A. Game, and R. M. McCulloch, J. Neurochem., 25, 803 (1975). 111 R. D. Allan, D. R. Curtis, P. M. Headley, G. A. R. Johnston, D. Lodge, and B. Twitchin, J. Neurochem., 34, 652 (1980). 112 R. W. Olsen and J. C. Venter, Eds., Benzodiazepine-GABA Receptors and Chloride Channels: Structural and Functional Properties, Alan R. Liss, New York, 1986. 113 J. F. Tallman, in The GABA Receptors, S. J. Enna, Ed., The Humana Press, Clifton, N.J., 1983, p. 93. 114 E. J. Peck, J. M. Schaeffer, and J. H. Clark, Biochem. Biophys. Res. Commun., 52, 394 (1973). 115 S. R. Zukin, A. B. Young, and S. H. Snyder, Proc. Natl. Acad. Sci. USA, 71, 4802 (1974). 116 A. M. Morin and C. Wasterlain, Life Sci., 26, 1239 (1980). 117 P. Krogsgaard-Larsen, A. Snowman, S. C. Lummis, and R. W. Olsen, J. Neurochem., 37, 401 (1981). 118 H. Möhler and T. Okada, Mol. Pharmacol., 14, 256 (1978). 119 R. W. Olsen and A. M. Snowman, J. Neurochem., 41, 1653 (1983). 120 M. Heaulme, J.-P. Chambon, E. Leyris, C. G. Wermuth, and K. Biziere, Neuropharmacology, 25, 1279 (1986). 121 R. W. Olsen, M. O. Bergman, P. C. Van Ness, S. C. Lummis, A. E. Watkins, C. Napias, and D. V. Greenlee, Mol. Pharmacol., 19, 217 (1981). 122 N. J. M. Birdsall, A. S. V. Burgen, and E. C. Hulme, in Cholinergic Mechanisms and Psychopharmacology, D. J. Jenden, Ed., Plenum, New York, 1977, p. 25. 123 R. C. Frere, R. L. MacDonald, and A. B. Young, Brain Res., 244, 145 (1982). 124 L. M. Nowak, A. B. Young, and R. L. MacDonald, Brain Res., 244, 155 (1982). 125 P. Schoch, J. G. Richards, P. Häring, B. Takacs, C. Stähli, T. Staehelin, W. Haefely, and H. Möhler, Nature (London), 314, 168 (1985). 126 E. Sigel, F. A. Stephenson, C. Mamalaki, and E. A. Barnard, J. Biol. Chem., 258, 6965 (1983). 127 D. A. Mathers, Synapse, 1, 96 (1987). 128 R. F. Squires and C. Braestrup, Nature (London), 266, 732 (1977). 129 H. Möhler and T. Okada, Science, 198, 849 (1977). 130 R. W. Olsen, J. Neurochem., 37, 1 (1981). 131 R. F. Squires, J. E. Casida, M. Richardson, and E. Saederup, Mol. Pharmacol., 23, 326 (1983). 132 J. Seifert and J. E. Casida, J. Neurochem., 44, 110 (1985). 133 J. Hebebrand, W. Friedl, B. Unverzagt, and P. Propping, J. Neurochem., 47, 790 (1986). 134 P. Supavilai and M. Karobath, J. Neurochem., 36, 798 (1981). 135 S.-S. Pong and C. C. Wang, J. Neurochem., 38, 375 (1982). 136 M. Williams and E. A. Risley, J. Neurochem., 42, 745 (1984). 137 G. Maksay and M. K. Ticku, J. Neurochem., 44, 480 (1985). 138 G. A. R. Johnston, in The GABA Receptors, S. J. Enna, Ed., The Humana Press, Clifton, N.J., 1983, p. 107. 139 J. K. Wamsley, D. R. Gehlert, and R. W. Olsen, in Benzodiazepine—GABA Receptors and Chloride Channels: Structural and Functional Properties, R. W. Olsen and J. C. Venter, Eds., Alan R. Liss, New York, 1986, p. 299. 140 J. R. Hammond and I. L. Martin, J. Neurochem., 47, 1161 (1986). 141 J. B. Fischer and R. W. Olsen, in Benzodiazepine—GABA Receptors and Chlorida Channels: Structural and Functional Properties, R. W. Olsen and J. C. Venter, Eds., Alan R. Liss, New York, 1986, p. 241. 142 R. D. Allan and G. A. R. Johnston, Med. Res. Rev., 3, 91 (1983). 143 P. Krogsgaard-Larsen, P. Jacobsen, and E. Falch, in The GABA Receptors, S. J. Enna, Ed., The Humana Press, Clifton, N.J., 1983, p. 149. 144 O. M. Larsson, P. Thorbek, P. Krogsgaard-Larsen, and A. Schousboe, J. Neurochem., 37, 1509 (1981). 145 P. Krogsgaard-Larsen, G. A. R. Johnston, D. Lodge, and D. R. Curtis, Nature ( London), 268, 53 (1977). 146 P. Krogsgaard-Larsen, H. Hjeds, D. R. Curtis, D. Lodge, and G. A. R. Johnston, J. Neurochem., 32, 1717 (1979). 147 A. Schousboe, O. M. Larsson, J. D. Wood, and P. Krogsgaard-Larsen, Epilepsia, 24, 531 (1983). 148 A. Schousboe, O. M. Larsson, L. Hertz, and P. Krogsgaard-Larsen, Drug Dev. Res., 1, 115 (1981). 149 G. A. R. Johnston, A. L. Stephanson, and B. Twitchin, J. Neurochem., 26, 83 (1976). 150 O. M. Larsson, P. Krogsgaard-Larsen, and A. Schousboe, J. Neurochem., 34, 970 (1980). 151 N. Seiler, S. Sarhan, P. Krogsgaard-Larsen, H. Hjeds, and A. Schousboe, Gen. Pharmacol., 16, 509 (1985). 152 P. Krogsgaard-Larsen, J. Med. Chem., 24, 1377 (1981). 153 R. D. Allan, H. W. Dickenson, and J. Fong, Eur. J. Pharmacol., 122, 339 (1986). 154 L. L. Iversen and J. S. Kelly, Biochem. Pharmacol., 24, 933 (1975). 155 O. M. Larsson, R. Griffiths, I. C. Allen, and A. Schousboe, J. Neurochem., 47, 426 (1986). 156 P. Krogsgaard-Larsen, E. Falch, M. J. Peet, J. D. Leah, and D. R. Curtis, in CNS Receptors—From Molecular Pharmacology to Behavior, P. Mandel and F. V. DeFeudis, Eds., Raven, New York, 1983, p. 1. 157 P. Krogsgaard-Larsen, L. Nielsen, U. Madsen, and E. Ø. Nielsen, in Fast and Slow Chemical Signalling in the Nervous System, L. L. Iversen and E. Goodman, Eds., Oxford Science Publishers, Oxford, 1986, p. 75. 158 G. A. R. Johnston, R. D. Allan, P. R. Andrews, S. M. E. Kennedy, and B. Twitchin, in Advances in Pharmacology and Therapeutics, Vol. 2, P. Simon, Ed., Pergamon, Oxford, 1978, p. 11. 159 P. Krogsgaard-Larsen, P. Lenicque, and P. Jacobsen, in Handbook of Stereoisomers: Drugs in Psychopharmacology, D. F. Smith, Ed., CRC Press, Boca Raton, FL, 1984, p. 369. 160 D. Burke, C. J. Andrews, and L. Knowles, J. Neurol. Sci., 14, 199 (1971). 161 R. Kerwin and C. Pycock, J. Pharm. Pharmacol., 30, 622 (1978). 162 D. R. Curtis, D. Lodge, J. C. Bornstein, and M. J. Peet, Exp. Brain Res., 42, 158 (1981). 163 N. G. Bowery, D. R. Hill, and A. L. Hudson, Neuropharmacology, 21, 391 (1982). 164 R. P. Weatherby, R. D. Allan, and G. A. R. Johnston, J. Neurosci. Methods, 10, 23 (1984). 165 G. A. R. Johnston, M. H. Hailstone, and C. G. Freeman, J. Pharm. Pharmacol., 32, 230 (1980). 166 H.-R. Olpe, A. Glatt, and W. Bencze, Brain Res. Bull., 5(Suppl. 2), 507 (1980). 167 R. D. Allan and H. Tran, Aust. J. Chem., 34, 2641 (1981). 168 R. D. Allan and G. A. R. Johnston, personal communication. 169 N. G. Bowery, D. R. Hill, and A. L. Hudson, in Problems in GABA Research from Brain to Bacteria, Y. Okada and E. Roberts, Eds., Excerpta Medica, Amsterdam, 1982, p. 302. 170 M. Karobath, P. Placheta, M. Lippitsch, and P. Krogsgaard-Larsen, Nature ( London), 278, 748 (1979). 171 I. L. Martin and J. M. Candy, Neuropharmacology, 17, 993 (1978). 172 J. F. Tallman, J. W. Thomas, and D. W. Gallagher, Nature (London), 274, 383 (1978). 173 P. Krogsgaard-Larsen, E. Falch, and P. Jacobsen, in Actions and Interactions of GABA and Benzodiazepines, N. G. Bowery, Ed., Raven, New York, 1984, p. 109. 174 P. Ferrero, A. Guidotti, and E. Costa, Proc. Natl. Acad. Sci. USA, 81, 2247 (1984). 175 J. H. Skerritt, M. Willow, and G. A. R. Johnston, Neurosci. Lett., 29, 63 (1982). 176 G. Biggio, A. Concas, M. Serra, M. Salis, M. G. Corda, V. Nurchi, G. Crisponi, and G. L. Gessa, Brain Res., 305, 13 (1984). 177 J. Kardos, G. Blasko, and M. Simonyi, Arzneim.-Forsch., 36, 939 (1986). 178 M. G. Corda, E. Sanna, A. Concas, O. Giorgi, E. Ongini, V. Nurchi, T. Pintori, G. Crisponi, and G. Biggio, J. Neurochem., 47, 370 (1986). 179 M. Browner, J. W. Ferkany, and S. J. Enna, J. Neurosci., 1, 514 (1981). 180 P. Supavilai and M. Karobath, Neurosci. Lett., 19, 337 (1980). 181 E. H. F. Wong and L. L. Iversen, J. Neurochem., 44, 1162 (1985). 182 C. J. Roberts, P. Krogsgaard-Larsen, and R. J. Walker, Comp. Biochem. Physiol., 69C, 7 (1981). 183 D. R. Curtis, personal communication. 184 R. W. Olsen, E. W. Snowhill, and J. K. Wamsley, Eur. J. Pharmacol., 99, 247 (1984). 185 H. Möhler and T. Okada, Nature ( London), 267, 65 (1977). 186 H. Möhler, in GABA—Biochemistry and CNS Functions, P. Mandel and F. V. DeFeudis, Eds., Plenum, New York, 1979, p. 355. 187 S. J. Enna, J. F. Collins, and S. H. Snyder, Brain Res., 124, 185 (1977). 188 N. G. Bowery, J. F. Collins, G. Cryer, T. D. Inch, and N. J. McLaughlin, in GABA—Biochemistry and CNS Functions, P. Mandel and F. V. DeFeudis, Eds., Plenum, New York, 1979, p. 339. 189 J. Kardos, G. Blasko, P. Kerekes, I. Kovacs, and M. Simonyi, Biochem. Pharmacol., 33, 3537 (1984). 190 B. H. Gähwiler, R. Maurer, and H. J. Wüthrich, Neurosci. Lett., 45, 311 (1984). 191 J. C. Michaud, J. M. Mienville, J.-P. Chambon, and K. Biziere, Neuropharmacology, 25, 1197 (1986). 192 B. D. Gynther and D. R. Curtis, Neurosci. Lett., 68, 211 (1986). 193 M. Heaulme, J.-P. Chambon, R. Leyris, J.-C. Molimard, C. G. Wermuth, and K. Biziere, Brain Res., 384, 224 (1986). 194 N. T. Buu, J. Duhaime, and O. Kuchel, Life Sci., 35, 1083 (1984). 195 N. G. Bowery, D. R. Hill, A. L. Hudson, A. Doble, D. N. Middlemiss, J. Shaw, and M. Turnbull, Nature ( London), 283, 92 (1980). 196 P. S. Callery and L. A. Geelhaar, J. Neurochem., 43, 1631 (1984). 197 M. Muhyaddin, P. J. Roberts, and G. N. Woodruff, Br. J. Pharmacol., 77, 163 (1982). 198 R. D. Allan and H. W. Dickinson, Eur. J. Pharmacol., 120, 119 (1986). 199 D. I. B. Kerr, J. Ong, R. H. Prager, B. D. Gynther and D. R. Curtis, Brain Res., 405, 150 (1987). 200 P. Krogsgaard-Larsen and G. A. R. Johnston, J. Neurochem., 25, 797 (1975). 201 M. C. W. Minchin, J. Neurochem., 32, 1519 (1979). 202 D. R. Riddall, M. J. Leach, and A. N. Davison, J. Neurochem., 27, 835 (1976). 203 G. A. R. Johnston, A. L. Stephanson, and B. Twitchin, J. Pharm. Pharmacol., 29, 240 (1977). 204 G. A. R. Johnston and B. Twitchin, Br. J. Pharmacol., 59, 218 (1977). 205 J. R. Simon and D. L. Martin, Arch. Biochem. Biophys., 157, 348 (1973). 206 P. Krogsgaard-Larsen, K. Thyssen, and K. Schaumburg, Acta Chem. Scand., B32, 327 (1978). 207 J. D. Wood, D. Tsui, and J. W. Phillis, Can. J. Physiol. Pharmacol., 57, 581 (1979). 208 S. L. Early, E. K. Michaelis, and M. P. Mertes, Biochem. Pharmacol., 30, 1105 (1982). 209 F. E. Ali, W. E. Bondinell, P. A. Dandridge, J. S. Frazee, E. Garvey, G. R. Girard, C. Kaiser, T. W. Ku, J. J. Lafferty, G. I. Moonsammy, H.-J. Oh, J. A. Rush, P. E. Setler, O. D. Stringer, J. W. Venslavsky, B. W. Volpe, L. M. Yunger, and C. L. Zirkle, J. Med. Chem., 28, 653 (1985). 210 L. M. Yunger, P. J. Fowler, P. Zarevics, and P. E. Setler, J. Pharmacol. Exp. Ther., 228, 109 (1984). 211 O. M. Larsson, E. Falch, P. Krogsgaard-Larsen, and A. Schousboe, J. Neurochem. (1988), in press. 212 C. Müller-Uri, E. A. Singer, and W. Fleischhacker, J. Med. Chem., 29, 125 (1986). 213 P. M. Beart and G. A. R. Johnston, Brain Res., 49, 459 (1973). 214 G. A. R. Johnston, R. D. Allan, S. M. E. Kennedy, and B. Twitchin, in GABA-Neurotransmitters. Pharmacochemical, Biochemical and Pharmacological Aspects, P. Krogsgaard-Larsen, J. Scheel-Krüger, and H. Kofod, Eds., Munksgaard, Copenhagen, 1979, p. 149. 215 G. A. R. Johnston, D. R. Curtis, P. M. Beart, C. J. A. Game, R. M. McCulloch, and B. Twitchin, J. Neurochem., 24, 157 (1975). 216 R. B. Silverman, S. C. Durkee, and B. J. Invergo, J. Med. Chem., 29, 764 (1986). 217 L. J. Fowler, D. H. Lovell, and R. A. John, J. Neurochem., 41, 1751 (1983). 218 L. J. Fowler and P. Krogsgaard-Larsen, unpublished. 219 P. Krogsgaard-Larsen and G. A. R. Johnston, J. Neurochem., 30, 1377 (1978). 220 C. Danzig and M. J. Jung, in Chemical and Biological Aspects of Vitamin B6, Catalysis: Part A, A. E. Evangelopoulos, Ed., Alan R. Liss, New York, 1984, p. 377. 221 B. W. Metcalf, M. J. Jung, B. Lippert, P. Casara, P. Böhlen, and P. J. Schechter, in GABA-Neurotransmitters. Pharmacochemical, Biochemical and Pharmacological Aspects, P. Krogsgaard-Larsen, J. Scheel-Krüger, and H. Kofod, Eds., Munksgaard, Copenhagen, 1979, p. 236. 222 M. J. Jung, J. G. Heydt, and P. Casara, Biochem. Pharmacol., 33, 3717 (1984). 223 R. B. Silverman, B. J. Invergo, and J. Mathew, J. Med. Chem., 29, 1840 (1986). 224 B. S. Meldrum and K. Murugaiah, Eur. J. Pharmacol., 89, 149 (1983). 225 A. Schousboe, O. M. Larsson, and N. Seiler, Neurochem. Res., 11, 1497 (1986). 226 P. Krogsgaard-Larsen, E. Falch, and V. Christensen, Drugs of the Future, 9, 597 (1984). 227 W. Löscher, Eur. J. Pharmacol., 110, 103 (1985). 228 W. S. Schwark and W. Löscher, Naunyn-Schmiedeberg's Arch. Exp. Path. Pharmak., 329, 367 (1985). 229 A. Schousboe, H. Hjeds, J. Engler, P. Krogsgaard-Larsen, and J. D. Wood, J. Neurochem., 47, 758 (1986). Citing Literature Volume8, Issue1January/March 1988Pages 27-56 ReferencesRelatedInformation

Referência(s)